Stem cell culture supernatant treatment
What is stem cell culture supernatant?
This is the supernatant obtained when mesenchymal stem cells (MSCs) are cultured. MSCs, also known as somatic stem cells, are cells with the ability to divide and differentiate. Dividing is the ability to divide and increase the number of identical cells, while differentiating is the ability to develop into other cells such as fat cells, bone cells, and chondrocytes. Under the Act on Safety Assurance of Regenerative Medicine, mesenchymal stem cells are currently being used to treat a variety of diseases, including spinal cord injury, central nervous system disorders, diabetes, chronic pain, osteoarthritis, wrinkles and sagging skin, atopic dermatitis, and diabetes. The reason they are being used to treat such a wide range of diseases is because the various cytokines, growth factors, and exosomes produced by MSCs can repair a wide variety of cells and tissues.
Stem cell conditioned medium contains the above substances produced by MSCs, so it is expected to have the same effects as MSC administration. Furthermore, the cells used to produce stem cell conditioned medium include adipose-derived MSCs, dental pulp-derived MSCs, and umbilical cord-derived MSCs, and it is expected that there will be some differences in the components contained.
Application Areas
-
wound
-
Osteoarthritis
-
arteriosclerosis
-
chronic pain
-
central nervous system disorders
-
Male Erectile Dysfunction (ED)
-
Rheumatism
-
Ischemic heart disease
-
diabetes
-
Renal dysfunction
-
Liver dysfunction
-
Alzheimer's disease
-
Spinal cord injury
-
bone regeneration
-
Periodontal tissue regeneration
Treatment methods
Administration is by systemic intravenous injection, or by local injection into the subcutaneous, intradermal, muscle, or joint cavity, or by nasal drops.
The administration method chosen will depend on the purpose of treatment, and the amount of stem cell conditioned medium administered will also vary depending on the purpose of treatment, pathological condition, etc.
Treatment overview
This treatment is an elective medical treatment.
Treatment period and number of times
The treatment will vary depending on the patient's condition and symptoms, so we will decide after you have examined us.
Cost (free medical treatment)
33,000 yen (tax included) to 110,000 yen (tax included)
Risks and side effects
Redness, swelling, and internal bleeding may occur at the injection site.
You may experience dizziness or cold sweats during or after the infusion.
Regarding elective medical treatment using unapproved drugs, etc.
● Clearly state that the drug is an unapproved drug, and clearly state the source of acquisition, etc.
The stem cell culture supernatant used in this treatment has not been approved under the Pharmaceutical and Medical Device Act. In Japan, unapproved medical devices can be used at the physician's own risk.
● Availability of domestically approved drugs, etc.
Currently, there are no other drugs approved in Japan that have the same properties as those used in this treatment.
● Information on safety in other countries
There is no clear information on the possibility of serious risks in other countries either.